Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades.

Authors

Derek J Bivona
Pim J A Oomen
Yu Wang
Frances L Morales
Mohamad Abdi
Xu Gao
Rohit Malhotra
Andrew Darby
Nishaki Mehta, Beaumont Health
Oliver J Monfredi

Document Type

Article

Publication Date

9-22-2023

Publication Title

J Cardiovasc Dev Dis

Abstract

As the mechanism for worse prognosis after cardiac resynchronization therapy (CRT) upgrades in heart failure patients with RVP dependence (RVP-HF) has clinical implications for patient selection and CRT implementation approaches, this study's objective was to evaluate prognostic implications of cardiac magnetic resonance (CMR) findings and clinical factors in 102 HF patients (23.5% female, median age 66.5 years old, median follow-up 4.8 years) with and without RVP dependence undergoing upgrade and de novo CRT implants. Compared with other CRT groups, RVP-HF patients had decreased survival (

Volume

10

Issue

10

First Page

409

Recommended Citation

Bivona DJ, Oomen PJA, Wang Y, Morales FL, Abdi M, Gao X, et al. [Mehta N] Cardiac magnetic resonance, electromechanical activation, kidney function, and natriuretic peptides in cardiac resynchronization therapy upgrades. J Cardiovasc Dev Dis. 2023 Sep 22;10(10):409. doi: 10.3390/jcdd10100409. PMID: 37887856.

DOI

10.3390/jcdd10100409

ISSN

2308-3425

PubMed ID

37887856